Lithium treatment for psychiatric disorders.

Area of Science:

• Psychiatry
• Pharmacology

Background:

• Lithium has been used globally since 1949 but gained significant traction in US psychiatry recently.
• Previous concerns regarding lithium toxicity, often linked to its use as a salt substitute, have been addressed.

Purpose of the Study:

• To highlight the essential knowledge physicians require for safe and effective lithium therapy.
• To underscore lithium's revolutionary impact on treating major affective disorders and its research potential.

Main Methods:

• Review of diagnostic criteria for major affective disorders.
• Analysis of lithium's indications, contraindications, and treatment principles.
• Evaluation of pre-treatment assessments, blood level monitoring, and toxicity signs.

Main Results:

• Lithium is confirmed as a safe and effective medication when used appropriately.
• Physician familiarity with diagnostic schemes and treatment protocols is crucial for optimal outcomes.
• Monitoring blood levels and recognizing toxicity signs are key components of safe lithium management.

Conclusions:

• Lithium therapy has transformed the management of major affective disorders.
• Safe and effective use necessitates comprehensive physician understanding of its application and monitoring.
• Lithium's established safety profile supports its continued role and opens new research avenues in emotional regulation.